Robeco Institutional Asset Management B.V. Acquires 106,513 Shares of Cigna Group $CI

Robeco Institutional Asset Management B.V. boosted its holdings in Cigna Group (NYSE:CI) by 57.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 292,602 shares of the health services provider’s stock after acquiring an additional 106,513 shares during the period. Robeco Institutional Asset Management B.V. owned 0.11% of Cigna Group worth $79,538,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Evercore Wealth Management LLC lifted its holdings in shares of Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after purchasing an additional 35 shares in the last quarter. Independence Bank of Kentucky grew its position in shares of Cigna Group by 2.6% in the second quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock valued at $409,000 after purchasing an additional 37 shares during the last quarter. West Family Investments Inc. increased its stake in shares of Cigna Group by 4.2% during the 2nd quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock worth $253,000 after purchasing an additional 37 shares in the last quarter. WPG Advisers LLC increased its stake in shares of Cigna Group by 24.5% during the 1st quarter. WPG Advisers LLC now owns 203 shares of the health services provider’s stock worth $54,000 after purchasing an additional 40 shares in the last quarter. Finally, Maripau Wealth Management LLC increased its stake in shares of Cigna Group by 4.0% during the 1st quarter. Maripau Wealth Management LLC now owns 1,074 shares of the health services provider’s stock worth $287,000 after purchasing an additional 41 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cigna Group

In related news, insider Everett Neville sold 617 shares of the company’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Cigna Group Stock Performance

Cigna Group stock opened at $304.74 on Thursday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $311.34. The stock’s 50-day moving average is $280.49 and its 200-day moving average is $282.73. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company has a market cap of $80.53 billion, a price-to-earnings ratio of 12.61, a price-to-earnings-growth ratio of 1.03 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $71.56 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same period in the previous year, the company posted $7.20 earnings per share. Cigna Group’s revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts anticipate that Cigna Group will post 30.50 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of recent research reports. Wells Fargo & Company upped their target price on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their target price for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Piper Sandler set a $370.00 price objective on Cigna Group and gave the stock an “overweight” rating in a research report on Friday, October 2nd. Guggenheim lifted their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Finally, Evercore initiated coverage on Cigna Group in a report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target for the company. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $338.24.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.